Family Medicine & Primary Care Review

Full text

4/2024 vol. 26
Review paper

Assessment of the impact of COVID-19 on the hearing organ

Jan Piotrowski 1
,
Bianka Nowińska 2
,
Izabela Hądzlik 2
  1. Jan Mikulicz-Radecki University Clinical Hospital, Wroclaw, Poland
  2. 4. Military Clinical Hospital SP ZOZ, Wroclaw, Poland
Family Medicine & Primary Care Review 2024; 26(4): 549–551
DOI: https://doi.org/10.5114/fmpcr.2024.144927
Data publikacji online: 2024/12/29
Article file
18 FM&PCR 4 24 - R - Piotrowski - 1510 - Assessment.pdf
Confronting perimenopausal women’s knowledge of coronary heart disease with their health behaviours. Controversial role of hormone replacement therapy in the protection of coronary heart disease
  1. Maharaj S, Bello Alvarez M, Mungul S, et al. Otologic dysfunction in patients with COVID-19: A systematic review. Laryngoscope Investig Otolaryngol 2020; 5(6): 1192–1196, doi: 10.1002/lio2.498.
  2. Kilic O, Kalcioglu MT, Cag Y, et al. Could sudden sensorineural hearing loss be the sole manifestation of COVID-19? An investigation into SARSCOV-2 in the etiology of sudden sensorineural hearing loss. Int J Infect Dis 2020; 97: 208–211, doi: 10.1016/j.ijid.2020.06.023.
  3. Koumpa FS, Forde CT, Manjaly JG. Sudden irreversible hearing loss post COVID-19. BMJ Case Rep 2020; 13(11): e238419, doi: 10.1136/bcr-2020-238419.
  4. Saniasiaya J. Hearing Loss in SARS-CoV-2: What Do We Know? Ear Nose Throat J 2021; 100(2_suppl): 152S–154S, doi: 10.1177/ 0145561320946902.
  5. Dharmarajan S, Bharathi MB, Sivapuram K, et al. Hearing Loss-a Camouflaged Manifestation of COVID 19 Infection. Indian J Otolaryngol Head Neck Surg 2021; 73(4): 1–5, doi: 10.1007/s12070-021-02581-1.
  6. Degen C, Lenarz T, Willenborg K. Acute Profound Sensorineural Hearing Loss After COVID-19 Pneumonia. Mayo Clin Proc 2020; 95(8): 1801–1803, doi: 10.1016/j.mayocp.2020.05.034.
  7. Mustafa MWM. Audiological profile of asymptomatic Covid-19 PCR-positive cases. Am J Otolaryngol 2020; 41(3): 102483, doi: 10.1016/j.amjoto.2020.102483.
  8. Tsuda T, Hanada Y, Wada K, et al. Efficacy of Intratympanic Glucocorticoid Steroid Administration Therapy as an Initial Treatment for Idiopathic Sudden Sensorineural Hearing Loss During the COVID-19 Pandemic. Ear Nose Throat J 2023; 102(12): 772–779, doi: 10.1177/01455613211032534.
  9. Andrianakis A, Moser U, Wolf A, et al. Intratympanic Triamcinolone Acetonide as a Salvage Treatment for Idiopathic Sudden Sensorineural Hearing Loss. Audiol Neurootol 2021; 26(6): 425–434, doi: 10.1159/000514086.
  10. Prayuenyong P, Kasbekar AV, Baguley DM. Clinical Implications of Chloroquine and Hydroxychloroquine Ototoxicity for COVID-19 Treatment: A Mini-Review. Front Public Health 2020; 8: 252, doi: 10.3389/fpubh.2020.00252.
  11. Dusan M, Milan S, Nikola D. COVID-19 caused hearing loss. Eur Arch Otorhinolaryngol 2021; 279: 2363–2372, doi: 10.1007/s00405-021-06951-x.
  12. Cohen BE, Durstenfeld A, Roehm PC. Viral causes of hearing loss: a review for hearing health professionals. Trends Hear 2014; 18: 2331216514541361, doi: 10.1177/2331216514541361.
  13. Kuhn M, Heman-Ackah SE, Shaikh JA, et al. Sudden sensorineural hearing loss: a review of diagnosis, treatment, and prognosis. Trends Amplif 2011; 15(3): 91–105, doi: 10.1177/1084713811408349.
  14. Özçelik Korkmaz M, Eğilmez OK, Özçelik MA, et al. Otolaryngological manifestations of hospitalised patients with confirmed COVID-19 infection. Eur Arch Otorhinolaryngol 2021; 278(5): 1675–1685, doi: 10.1007/s00405-020-06396-8.
  15. Karimi-Galougahi M, Naeini AS, Raad N, et al. Vertigo and hearing loss during the COVID-19 pandemic – is there an association? Acta Otorhinolaryngol Ital 2020; 40(6): 463–465, doi: 10.14639/0392-100X-N0820.
  16. Fancello V, Hatzopoulos S, Corazzi V, et al. SARS-CoV-2 (COVID-19) and audio-vestibular disorders. Int J Immunopathol Pharmacol 2021; 35: 20587384211027373, doi: 10.1177/20587384211027373.
Copyright: © 2024 Family Medicine & Primary Care Review. This is an Open Access article distributed under the terms of the Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International (CC BY-NC-SA 4.0) License (http://creativecommons.org/licenses/by-nc-sa/4.0/), allowing third parties to copy and redistribute the material in any medium or format and to remix, transform, and build upon the material, provided the original work is properly cited and states its license.
Share
without publication fees
Coverage in
Integrated with